Newsroom
TBMC and Caarlogic Biomed Initiate Lentiviral Vector Collaboration, Bridging Taiwan’s Advanced Therapy R&D and Manufacturing
Taiwan Bio-Manufacturing Corporation (TBMC), a premier contract research,development, and manufacturing organization (CRDMO), today announced a
TBMC Partners with MVC to Advance Second-Generation Multivalent Enterovirus Vaccine Development
Taiwan Bio-Manufacturing Corporation (TBMC) today announced its collaboration with Medigen Vaccine Biologics Corp. (MVC, 6547.TWO), Taiwan’s leading vaccine company.
BIO Asia–Taiwan 2026 | TBMC Showcases Advanced Therapy Capabilities
July 16, 2026 BIO Asia–Taiwan 2026 | TBMC Showcases Advanced Therapy Capabilities BIO Asia–Taiwan 2026 takes place from July 16–19, 2026. During the event, TBMC
TBMC Opens GMP Facility in Zhubei, Marking a New Milestone in Advanced Biomanufacturing
Taiwan Bio-Manufacturing Corporation (TBMC) today held the opening ceremony of its GMP facility in Zhubei, located at the Hsinchu Biomedical Science Park. The facility …
PharmaBoardroom Interview: David Chang, CEO of TBMC, on Scaling Advanced Biomanufacturing in Taiwan
In an interview with PharmaBoardroom, Dr. David Chang, CEO of TBMC, shares his vision to build a leading cell and gene therapy CDMO in Taiwan.
The Chemical Daily: Taiwan Special Feature | Interview with TBMC CEO David Chang
Taiwan Bio-Manufacturing Corporation (TBMC), a CDMO focused on advanced therapeutics, is currently building a GMP-compliant manufacturing facility in the Hsinchu Biomedical Science Park…
